MARKET RADAR
SENSEX     NIFTY      Refresh

SBI Magnum Pharma Fund (D)

40.250
0.01 (0.02%)
NAV as on May-25-2012

Not Ranked

This scheme is not ranked by CRISIL.
View Top ranked funds in other categories

Benchmark Index:
 
View Historic Graph From     To     

Returns (NAV as on May-25-2012)

Period Returns (%) Rank #
1 mth -1.4 1
3 mth 7.8 1
6 mth 10.3 1
1 year 10.3 1
2 year 12.7 1
3 year 25.5 2
5 year 6.6 3

# Moneycontrol Rank within 3 Sector - Pharma & Healthcare Schemes.

Absolute Returns (in %)

Year Qtr 1 Qtr 2 Qtr 3 Qtr 4 Annual
2012 9.4 - - - -
2011 -6.1 6.8 -8.3 2.9 -5.6
2010 4.8 9.8 -0.3 9.5 29.8
2009 -11.1 43.8 26.2 -0.2 81.4
2008 -27.0 6.7 -10.5 -27.8 -50.2
2007 -7.2 12.9 -9.7 11.7 5.7

View where it stands within its peers

* Returns over 1 year are Annualised

Performance

Fund returns v/s Category average (Sector - Pharma & Healthcare)

* Returns over 1 year are Annualised
  1 mth (%) 3 mth (%) 6 mth (%) 1 yr (%) 2 yr (%) 3 yr (%) 5yr (%)
Fund Returns -1.4 7.8 10.3 10.3 12.7 25.5 6.6
Category avg -2.3 5.8 7.2 5.1 9.8 27.1 12.9
Difference of Fund returns and Category returns 0.9 2.0 3.1 5.2 2.9 -1.6 -6.3
Best of category -1.4 7.8 10.3 10.3 12.7 31.8 19.9
Worst of category -2.8 3.5 3.1 1.5 7.9 23.9 6.6
Benchmark returns # -1.5 5.7 10.9 6.4 11.3 24.2 12.0
Difference of Fund returns and Benchmark returns 0.1 2.1 -0.6 3.9 1.4 1.3 -5.4
# Benchmark Index: BSE HEALTHCARE

Investment Info

Investment Objective

To provide the investors maximum growth opportunity through equity investments in stocks of growth oriented sectors of the economy. There are five sub-funds dedicated to specific investment themes viz.Information Technology, Pharmaceuticals,FMCG, Contrarian (investment in stocks currently out of favour) and Emerging Businesses.

Scheme details

Fund Type Open-Ended
Investment Plan Dividend
Launch date Jul 31, 1999
Benchmark BSE HEALTHCARE
Asset Size (Rs cr) 41.05 (Mar-31-2012)
Minimum Investment Rs.2000
Last Dividend Rs.3.90 (Dec-31-2004) View Dividend History
Bonus N.A.
Fund Manager Tanmaya Desai
View performance of schemes managed by the Fund Manager
Notes N.A

Load Details

Entry Load N.A
Exit Load 1.00%
Load Comments Exit Load 1% if units are redeemed / switched-out within 1 year from the date of allotment.

Contact Details

Regd. Office 191 Maker Towers E, Cuffe Parade, Mumbai, 400005
Tel. No. 91 22 22180221/ 27
Fax No. 91 22 22189663
Email partnerforlife@sbimf.com
Website http://www.sbimf.com

Peer Comparison

Sector - Pharma & Healthcare Crisil Rank Assets (Rs.cr)
3mth (%) 6mth (%) 1yr (%) 3yr (%) 5yr (%)
Reliance Pharma Fund (G) Not Ranked
563.56 6.0 8.1 3.4 31.8 19.9
SBI Magnum Pharma Fund (G) Not Ranked
41.05 7.8 10.3 10.3 25.5 6.6
UTI Pharma & Health (G) Not Ranked
93.37 3.5 3.1 1.5 23.9 12.3
* Returns over 1 year are Annualised More »

Portfolio

Top Holdings (Apr 30, 12)

Equity Sector Value
(Rs cr)
Asset %
Dr Reddys Labs Pharmaceuticals - 14.31
Cipla Pharmaceuticals - 10.86
Divis Labs Pharmaceuticals - 9.94
Lupin Pharmaceuticals - 9.87
Cadila Health Pharmaceuticals - 8.96
Ipca Labs Pharmaceuticals - 7.02
Torrent Pharma Pharmaceuticals - 6.79
Wyeth Pharmaceuticals - 6.26
Sun Pharma Pharmaceuticals - 4.90
Novartis India Pharmaceuticals - 3.28

Full Portfolio

Sector Allocation (Apr 30, 12)

Sector %

1-Year

HighLow

Pharmaceuticals 94.25 98.60 90.13

View All Sectors

Asset Allocation (%)(Apr 30, 12)

Equity 94.25
Others 0.00
Debt 0.00
Mutual Funds N.A
Money Market 0.00
Cash / Call 5.75

View All

Concentration

Holdings (%)
Top 5 53.94
Top 10 82.19
Sector (%)
Top 3 94.25

News & Videos

News

Messages & Community